Association found between cystic fibrosis and gut microbiota composition and functionality
9 Oct 2017by Andreu Prados
A recent study has shown that CF and its antibiotic IV treatment are associated with different gut microbiota composition.
by Andreu Prados
A recent study has shown that CF and its antibiotic IV treatment are associated with different gut microbiota composition.
by GMFH Editing Team
Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN).
by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
by Andreu Prados
A recent study, led by Dr. Oluf Pedersen from the Faculty of Health and Medical Sciences at University of Copenhagen in Denmark, has found that dysbiosis of the human gut microbiota impacts the serum metabolome and contributes to the state of IR and metabolic syndrome.
Research shows that host-microbe interactions can regulate immune and metabolic pathways. Here, Fu and colleagues investigated the connection between the microbiota and selected risk factors for cardiovascular disease in humans: abnormal blood lipid levels and high body mass.
by Kristina Campbell
As MyNewGut, a research initiative involving thirty organizations from fifteen countries, continued to carry out its research program on prebiotic fibres and the gut microbiota, project participants held a workshop before the International Dietary Fibre Conference 2015 in Paris.
The Third International Congress of Translational Research in Human Nutrition (ICTRHN) took place in Clermont-Ferrand, France, on June 26 & 27, 2015.
by Fernando Aspiroz
At the second PreProSim -- Brazilian Congress on Pre, Pro and Synbiotics --, several sessions on June 16th covered the topic of metabolic disorders and obesity.
by Patrice D. Cani
A recent study (Chassaing, et al.) showed that two dietary emulsifiers -- carboxymethylcellulose and polysorbate-80 -- induced gut microbiota alteration and gut barrier dysfunction in mice, resulting in weight gain, low-grade inflammation, and metabolic disorders.
by Kristina Campbell
Amir Zarrinpar (MD, PhD) is a gastroenterologist with UC San Diego Health, and a researcher at The Salk Institute for Biological Studies.